Modeling the Health and Budgetary Impacts of a Team-based Hypertension Care Intervention That Includes Pharmacists
Conclusions:
Adopting a pharmacist-involved team-based hypertension model could substantially improve BP control and cardiovascular outcomes in the United States. Net cost-savings among groups 2 and 3 make a compelling case for Medicare, but favorable economics may also be possible for private insurers, particularly if innovations could moderately lower the cost of delivering an effective intervention.
Source: Medical Care - Category: Health Management Tags: Original Articles Source Type: research
More News: Cardiology | Cardiovascular | Economics | Health Management | Heart | Hypertension | Insurance | Insurers | Medicaid | Medicare | Stroke | Study | USA Health